A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting.
about
The new horizons of pharmacotherapy. Unexpected pharmacological actions and a new therapeutic strategy of phosphodiesterase-5 inhibitorsIntegrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies.The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (ComEthnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting.Overactive bladder in malesManagement of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia by general practitioners in JakartaCommonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey.Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review.Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.Combination pharmacological therapies for the management of benign prostatic hyperplasia.The evaluation and treatment of prostate-related LUTS in the primary care setting: the next STEP.Tadalafil - a therapeutic option in the management of BPH-LUTS.Randomized double-blind controlled clinical trials with herbal preparations of Serenoa repens fruits in treatment of lower urinary tract symptoms : An overview.Treatment of Concomitant OAB and BPH.Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients.Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?Diagnosis and management of benign prostatic hyperplasia in primary care.Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study.Clinical features of supervoiders who suffer from lower urinary tract symptoms: a propensity score-matching study.Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic.Tailoring pharmacotherapy for male lower urinary tract symptoms: A prospective, multicenter, observational trial.Early effect of dutasteride added to alpha-1 blocker therapy for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.Examining lower urinary tract symptom constellations using cluster analysis.Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational studyMinimally Invasive Therapies
P2860
Q27025700-C5FDEFA0-D6F1-440D-9984-F2826291DAB6Q30373008-19FAB80A-0284-4E1E-8D13-0514A6B70685Q33829176-6FD3CB7E-574F-4AD9-A8C3-7CFFCE9EB0FAQ34027912-C89EB2E3-9ED7-47D0-BAB0-0F43A0815E7CQ35076391-9D2DB2B2-3B69-4F08-89D4-275ED07DE794Q35207995-DAA47AF3-4574-4CAD-AB0F-8A29C57745A0Q35643437-5275443F-4ABA-4393-AC07-8A6DE59A3094Q36432096-8D894331-3041-49C7-B90B-F1820F6234BFQ37826454-E7BB9FBE-7870-4F60-AD39-1EEE8D4237EEQ37973041-D8FDF5B4-EE56-47E5-B4F7-78DE0D69DB08Q37994725-C3BD385F-8B29-4782-9289-544145312D21Q38136528-8E1D10AB-4B70-493B-8F9A-67CC01877DB0Q38171532-2F59B8B2-94F9-4092-9D5E-9CF1CD88B45AQ39024174-9DABD75D-AEE2-4159-8D01-C79D84DAF342Q39090324-A289223A-72C1-4813-83D1-1C7916EDC423Q39157031-26984BC1-E159-4EE8-9191-8B16F798D6E6Q39163861-6E6634AD-FE48-4E0B-ABF0-38697FB74413Q39990115-9AD6C4BB-C726-4E50-82E9-074DAB02D308Q40035548-56E4DF6E-77FA-4807-AB84-646E934D3B38Q41986288-B3811933-F592-49C9-9E51-5A25A8C26202Q42140433-E3CC1918-DDFF-4743-BDFB-E04127965703Q43644314-A414CCB5-3F74-45AE-8EB7-097ECEB893E7Q44125663-F380D2DF-D7D0-4CBF-881F-9DDCB0D693CDQ48139585-921FE7F0-0799-4E5C-9A5C-791E42ECBA33Q53091375-B24213AB-9DAA-4AE8-8837-6FBF374383FBQ53219069-7A384BB3-22DA-45A2-9C76-172021195BAFQ57474731-F5666A25-5BD0-42B7-A3B5-7771BCE45644Q57582176-92256A0A-426C-4667-9D7F-E81D0C827F26
P2860
A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A practical guide to the evalu ...... s in the primary care setting.
@en
type
label
A practical guide to the evalu ...... s in the primary care setting.
@en
prefLabel
A practical guide to the evalu ...... s in the primary care setting.
@en
P2093
P1476
A practical guide to the evalu ...... s in the primary care setting.
@en
P2093
MacDiarmid SA
Rosenberg MT
Staskin DR
P2860
P304
P356
10.1111/J.1742-1241.2007.01491.X
P577
2007-07-11T00:00:00Z